Adverum is looking for an Associate Scientist with knowledge of molecular biology to join our team in our Redwood City office. This position reports to a Senior Scientist/Team Leader. This person will be working with Research, Development, and Discovery. This role is responsible for developing, characterizing and validating optogenetic gene therapy vectors, and assisting with IND-enabling studies.
What you'll do:
- Support the execution of assays for discovery and translational research. Assay read-outs include ELISA, qPCR, FACS, SDS-PAGE, agarose gels and Western blot.
- Produce, purify, and characterize complex biological molecules like DNA, RNA, protein, and AAV.
- Maintenance, transfection and transduction of different cell types.
- Perform sample processing from a variety of tissue types.
- Order and maintain sufficient inventory of materials and reagents for planned laboratory activities.
- Follow established protocols and SOPs.
- Ensure accurate laboratory records and project updates.
- Participate in team meetings and present technical data.
- Must be comfortable in a fast-paced, small company environment.
- Be involved with development, qualification, and transfer of bioanalytical methods to support preclinical and clinical assays
- Present results, conclusions, and implications to project teams.
- Maintain excellent documentation of laboratory activities.
- Perform routine lab maintenance.
- Other responsibilities may be assigned as needed.
About you:
- Minimum of a biological science or similar Bachelor’s degree with 6-8 years’ of relevant experience in a biotech company, or a Master’s degree with 4-5 years’ of relevant experience, or an equivalent combination of education and experience.
- Broad knowledge base in molecular biology, and microbiology techniques.
- Expertise in a variety of laboratory techniques such as recombinant DNA technology, including cloning, DNA/RNA isolation and analysis, PCR, RT-PCR, qPCR is required.
- Expertise in sterile tissue culture techniques including, transfection, transduction, developing and maintaining cell lines is a must.
- Biochemical techniques including, western blot, flow cytometry, immunofluorescence, ELISA are highly desired.
- Hands-on experience with the execution of bioassays using technologies including qPCR, ddPCR, MSD, Luminex, flow cytometry and cell-based potency assays are advantageous.
- Experience with sample processing methods to support protein and nucleic acid detection from a variety of animal/human tissues.
- Experience with other gene expression and protein detection analytical methods.
- Must be proactive, co-operative, and willing to work in a small team environment.
- Excellent verbal and written communication skills.
- Proficient with MS Office and other commonly used software.
- Experience with data analysis software like Prism, FlowJo, ImageJ and SoftMax Pro are a plus.
- Background and understanding of AAV biology is preferable.
- AAV production experience is advantageous.
- Understanding or background with optogenetics and calcium imaging assays is also advantageous.
Adverum is a clinical-stage gene therapy company targeting unmet medical needs in ophthalmology and rare diseases. Adverum develops gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Adverum’s core capabilities include clinical development, novel vector discovery and in-house manufacturing expertise, specifically in scalable process development, assay development, and current Good Manufacturing Practices quality control.
At Adverum, Inclusion and Diversity are at our core. We believe in the power of being your authentic self. We strive to create the space which allows for everyone in our Adverum Community to not only feel safe but encouraged to speak, learn from each other, grow in their professions and be the very best versions of themselves no matter what their age, ethnic background, gender, origin, religion or sexual orientation.
Top Skills
What We Do
Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leveraging the research capabilities of its proprietary, intravitreal (IVT) platform, Adverum is developing durable, single-administration therapies, designed to be delivered in physicians’ offices, to eliminate the need for frequent ocular injections to treat these diseases. Adverum is evaluating its novel gene therapy candidate, ixoberogene soroparvovec (Ixo-vec, formerly referred to as ADVM-022), as a one-time, IVT injection for patients with neovascular or wet age-related macular degeneration. By overcoming the challenges associated with current treatment paradigms for these debilitating ocular diseases, Adverum aspires to transform the standard of care, preserve vision, and create a profound societal impact around the globe.